Inflammaging and osteoarthritis - therapeutic opportunities - Summary - MDSpire

Inflammaging and osteoarthritis - therapeutic opportunities

  • By

  • Megan Chan

  • Phoebe Low

  • Shi Chee Ong

  • Sze Mun Choy

  • Wen Xing Lee

  • Kah Yong Goh

  • Kanya Moolsuwan Ng

  • Kimberly Chua

  • Jia Ying Lee

  • Alvin Kunyao Guo

  • Jiang Jia

  • Eng King Tan

  • Hong-Wen Tang

  • Kenon Chua

  • June 23, 2026

  • 0 min

Share

Objective:

To summarize the roles and mechanisms of the senescence-associated secretory phenotype (SASP) in osteoarthritis (OA) and explore therapeutic strategies targeting inflammatory factors.

Approach:
    Key Findings:
    • SASP is associated with chronic inflammation and cartilage degradation in OA.
    • Key pro-inflammatory cytokines in OA include IL-1β, TNF, and IL-6, which disrupt joint tissue homeostasis.
    • Therapeutic agents targeting SASP-related pathways show potential in reducing inflammation and preserving cartilage.
    Interpretation:

    The review highlights the role of SASP-driven inflammation in OA and the need for targeted therapeutic strategies.

    Limitations:
    • The review does not provide specific clinical trial data or outcomes related to the discussed therapeutic approaches, and emerging therapies such as microRNA modulation and CRISPR/Cas9 editing require further validation in clinical settings.
    Conclusion:

    Targeting SASP-related pathways may provide new avenues for managing OA.

Original Source(s)

Related Content